MI-3454 is an Orally Active Menin-MLL1 Interaction Inhibitor
The protein-protein interaction between menin and MLL fusion proteins plays a critical role in the pathogenesis of MLL leukemia. The genetic disruption of this interaction abrogates the development of acute…